Relugolix and effectiveness

  • 6 replies
  • 190 subscribers
  • 375 views

Good evening,

I have a question around Relugolix to see whether others have experience of this hormone tablet and to seek some reassurance.

My OH was first diagnosed with advanced prostate cancer back in April 2024. He registered Gleason 9 and cancer was found in pelvis, hip, femur, lower spine and liver, following a PSA of 20.

Due to heart complications his treatment has been 'light'. After 18 months on Degaralix he was moved to a daily oral tablet - Relugolix. This seemed to be working well until last week when the PSA had risen from 0.5 to 1.6 in 8 weeks. HIs PSA has been 'negligible' (circa 0.4) for 30 months. There has been no action from anyone since then, partly because we have a routine oncology appointment in early November. However we are aware that Reluolix may not be as effective as Degaralix in reducing testosterone and we are of course hoping that it is the change in medication which has caused his PSA to rise and not the cancer gaining strength again. 

A bit of a broad question I'm afraid and it could mean many things, but has anyone else found their PSA rising after taking Relugolix for a few months, principally because it was found not to be as effective as 4 weekly hormone injections?

Thank you,

Jenny

  • Sorry to hear of your OH issues Jenny. I see that your diagnosis would normally be addressed with triplet therapy but heart issues preclude that option. When I was wavering over triplet therapy doublet therapy was recommended ie Relugolix + Darolutamide; triplet therapy is Relugolix then Darolutamide with 6 cycles of chemo. The 2 drugs (probably) continue indefinitely. I did have a PSA spike soon after first taking Relugolix - 0.86, 1.8 but then 0.37 and eventually down to < 0.025. I would ask about doublet therapy and an alternative to chemo such as Pluvicto.

    For info I'm being treated at Guildford; I would email your consultant's secretary with your questions & concerns - detail  better in writing.

    R+D are both 2nd generation (expensive!) HT drugs, only recently available on the NHS.

    For Darolutamide see eg www.prostate-cancer-research.org.uk/.../

  • Hi Jenny,

    Sorry to hear about this concerning rise in PSA. I have been on Relugolix for ten months and after a rapid drop in 2 months from 11 to 1.0 I remained undectable since then. My information is that it is equally effective as injections, possibly better as no risk of injection site issues and faster testosterone recovery if/when you exit. It also carries lower cardio risk which is useful for me as I have a pacemaker. So unfortunately, I think it unlikeley that the PSA rise is due to Relugolix and would definitely get the cause investigated further as it has increased so rapidly.

    I wish you all the best of luck in your OH's journey

    David

  • I can only agree with David. I changed from Prostap to Relugolix around 7 months ago mainly because testosterone can return much quicker when the time comes to stop and carries lower cardio risk. My last 2 PSA bloods have been 0.025 (undetectable). 

    I agree with David. Further investigation is needed. Best of Luck another Dave.

  • Thank you for your reply Jon41. Thank you for the helpful information around doublet therapy. I've taken your advice and emailed our consultant's secretary with my questions and I hope to hear back from him after the weekend. We live in Scotland. My OH has been precluded from chemo because of his heart, although, as you suggest, there may be alternatives. He was on Enzalutamide for about a year but struggled so much with fatigue and brain fog, side effects of the drug, that he eventually decided to come off it. 

    Best wishes for your future treatment and recovery,

    Jenny

  • Hi David, Thank you for your reply. Although your conclusion is not reassuring (for us) I'm grateful to have your feedback. I've been in touch now with both Oncology and urology. We are really dependent on our consultant oncologist to provide us with some answers or action. Unfortunately we have never felt particularly comfortable with our oncologist and even I, as the more assertive one and the one who often asks the questions, find it difficult to engage him in conversation.  I worry about my OH as he has no-one to turn to. His GP last spoke to him back in 2023 when he was diagnosed with heart failure.

    We've now been sitting on this raised PSA result for a week and there has been no communication with anyone, which is why I've taken to this Forum to start a conversation. Thank you for replying.

    Best wishes,

    Jenny

  • Thank you Dave for your helpful reply.

    Best wishes,

    Jenny